{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-204084","form_type":"8-K","ticker":"SEER","cik":"0001726445","company_name":"Seer, Inc.","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.816191+00:00","generated_at":"2026-05-14T23:57:00.191943+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Seer appoints Anthony Bazarko as Chief Commercial Officer","bullets":["Anthony Bazarko named CCO effective May 4, 2026; previously President & CEO of Biologos and CCO at Specific Diagnostics.","Bazarko brings over 20 years of commercial leadership in life sciences, diagnostics, and biotech.","He will lead Seer's Sales, Marketing, and Customer Experience to accelerate Proteograph Product Suite adoption.","CEO Omid Farokhzad cites Bazarko's record of commercial strategy as key to next growth phase."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-204084","json":"https://secwatch.observer/filing/0001193125-26-204084.json","markdown":"https://secwatch.observer/filing/0001193125-26-204084.md","text":"https://secwatch.observer/filing/0001193125-26-204084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726445/000119312526204084/0001193125-26-204084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726445/000119312526204084/ck0001726445-20260504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:57:00.191943+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}